Complications after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for treatment of peritoneal carcinomatosis: risk factors for ICU admission and morbidity prognostic score

For patients suffering from peritoneal carcinomatosis, cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is the only curative option. We focused on severe complications in the postoperative course of HIPEC.

Source: Surgical Oncology - November 6, 2015 Category: Surgery Authors: Sylvain Malfroy, Florent Wallet, Delphine Maucort-Boulch, Laurent Chardonnal, Nicolas Sens, Arnaud Friggeri, Guillaume Passot, Olivier Glehen, Vincent Piriou Tags: Review Source Type: research